麻豆传媒

Bladder, brain, and cervical cancer risks were higher in people with MS

Rates rose after USPSTF recommendation, but increase was uneven

Knowing what to look for can mean the difference between life and death

Bowel preparation protocols appeared protective in small study

Gastric cancer incidence was lower after adjusting for certain factors in post hoc analyses

Despite problematic dataset, risk/benefit profile not favorable with PD-L1 expression below 1

Alternative designs needed, researchers caution

Only a minority of patients adhered to SUNTRAC screening recommendations

26% of patients receiving tulisokibart achieved clinical remission vs 1% with placebo

Data since approvals suggest benefits limited to subgroups with PD-L1 expression of at least 1%

Drugmaker none-too-pleased with agency's request for additional studies

Limited benefit seen in patients with established cirrhosis, however

Adding lenvatinib, pembrolizumab to TACE significantly improved PFS, numerically improved OS

Agency advisors put their foot down on shaky science for Ocaliva in primary biliary cholangitis